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Closing the Brief Case: A Reactive HIV Rapid Antibody Test in a
Pregnant Woman
(See page 826 in this issue [doi:10.1128/JCM.02647-15] for case presentation and discussion.)
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ANSWERS TO SELF-ASSESSMENT QUESTIONS
1. After a positive HIV rapid antibody test, which of the fol-
lowing tests should be ordered next?
(a) HIV-1 Western blot assay.
(b) HIV-1 nucleic acid amplification test.
(c) HIV antigen/antibody immunoassay.
(d) HIV-1/2 differentiation assay.
Answer: c. According to the 2014 CDC recommendations
for the diagnostic testing of HIV, patients with positive
rapid antibody assay results should be tested by the fourth-
generation algorithm in its entirety. Therefore, the most
appropriate next test is theHIV antigen/antibody immuno-
assay.
2. In a low-risk patient, which of the following results require
confirmatory testing with a qualitative molecular assay for
HIV-1 as the next step?
(a) HIV antigen/antibody immunoassay positive and
HIV-1/2 differentiation assay negative.
(b) HIV antigen/antibody immunoassay positive and
HIV-1/2 differentiation assay positive.
(c) HIV rapid antibody test positive and HIV antigen/
antibody immunoassay negative.
(d) HIV rapid antibody test positive and HIV antigen/
antibody immunoassay positive.
Answer: a. The fourth-generation testing algorithm recom-
mends confirmatory testing using a qualitative molecular
technique for all patients with positive antigen/antibody
immunoassay positive and negative HIV-1/2 differentia-
tion assays. This is to detect possible cases of acute HIV-1.
3. Which of the following is not an advantage of using the
HIV-1/2 differentiation assay for serologic confirmation as
opposed to Western blot assay?
(a) An earlier time to positivity following infection.
(b) The ability to distinguish HIV-1 antibodies from
HIV-2 antibodies.
(c) The ability to rule out HIV infection based on a
negative result.
(d) A faster turnaround time.
Answer: c. HIV-1/2 differentiation has an earlier time to
positivity, faster turnaround time, and lower cost than
HIV-1 Western blotting. Negative results still require con-
firmation with a molecular test to rule out acute HIV.
TAKE-HOME POINTS
• Compared to third-generation antibody assays, fourth-gen-
eration antigen/antibody assays are more sensitive, more
specific, and capable of earlier detection of HIV infection.
• Testing for HIV by the fourth-generation algorithm entails
screening with an antigen/antibody assay and confirmatory
testing with an HIV-1/2 differentiation assay.
• Patients with a reactive antigen/antibody assay but nonreac-
tive HIV-1/2 differentiation assay should have molecular
testing performed to distinguish acute HIV infection from a
false-positive screen result.
• Rapid HIV antibody tests offer a quick turnaround time, but
reactive results should be confirmed using the fourth-gener-
ation algorithm.
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